Letter | Published:

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

Nature volume 504, pages 451455 (19 December 2013) | Download Citation

Abstract

Intestinal microbes provide multicellular hosts with nutrients and confer resistance to infection. The delicate balance between pro- and anti-inflammatory mechanisms, essential for gut immune homeostasis, is affected by the composition of the commensal microbial community. Regulatory T cells (Treg cells) expressing transcription factor Foxp3 have a key role in limiting inflammatory responses in the intestine1. Although specific members of the commensal microbial community have been found to potentiate the generation of anti-inflammatory Treg or pro-inflammatory T helper 17 (TH17) cells2,3,4,5,6, the molecular cues driving this process remain elusive. Considering the vital metabolic function afforded by commensal microorganisms, we reasoned that their metabolic by-products are sensed by cells of the immune system and affect the balance between pro- and anti-inflammatory cells. We tested this hypothesis by exploring the effect of microbial metabolites on the generation of anti-inflammatory Treg cells. We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by commensal microorganisms during starch fermentation, facilitated extrathymic generation of Treg cells. A boost in Treg-cell numbers after provision of butyrate was due to potentiation of extrathymic differentiation of Treg cells, as the observed phenomenon was dependent on intronic enhancer CNS1 (conserved non-coding sequence 1), essential for extrathymic but dispensable for thymic Treg-cell differentiation1,7. In addition to butyrate, de novo Treg-cell generation in the periphery was potentiated by propionate, another SCFA of microbial origin capable of histone deacetylase (HDAC) inhibition, but not acetate, which lacks this HDAC-inhibitory activity. Our results suggest that bacterial metabolites mediate communication between the commensal microbiota and the immune system, affecting the balance between pro- and anti-inflammatory mechanisms.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

Gene Expression Omnibus

Data deposits

Microarray data have been deposited in the Gene Expression Omnibus (GEO) under accession number GSE51263.

References

  1. 1.

    et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395–399 (2012)

  2. 2.

    & Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204–12209 (2010)

  3. 3.

    et al. Induction of intestinal TH17 cells by segmented filamentous bacteria. Cell 139, 485–498 (2009)

  4. 4.

    et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250–254 (2011)

  5. 5.

    et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 331, 337–341 (2011)

  6. 6.

    et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013)

  7. 7.

    et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808–812 (2010)

  8. 8.

    , & Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J. Nutr. 133, 3523–3528 (2003)

  9. 9.

    et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013)

  10. 10.

    et al. Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PLoS ONE 6, e19047 (2011)

  11. 11.

    et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115, 965–974 (2010)

  12. 12.

    , , , & Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity. Immunol. Cell Biol. 90, 95–100 (2012)

  13. 13.

    et al. Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell Rep. 1, 665–675 (2012)

  14. 14.

    , , & Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nature Rev. Drug Discov. 8, 969–981 (2009)

  15. 15.

    et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nature Med. 13, 1299–1307 (2007)

  16. 16.

    et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009)

  17. 17.

    et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69, 2826–2832 (2009)

  18. 18.

    , , & Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun. 303, 1047–1052 (2003)

  19. 19.

    et al. Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD. Blood 109, 5049–5057 (2007)

  20. 20.

    et al. Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection. Cell. Immunol. 274, 12–18 (2012)

  21. 21.

    et al. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways. Nature Immunol. 13, 1162–1170 (2012)

  22. 22.

    et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329–341 (2005)

  23. 23.

    , & Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunol. 8, 191–197 (2007)

  24. 24.

    et al. Measurement of short-chain fatty acids in human faeces using high-performance liquid chromatography: specimen stability. Ann. Clin. Biochem. 47, 447–452 (2010)

  25. 25.

    et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153–166 (2012)

Download references

Acknowledgements

This work was supported by the Robert Black Fellowship of the Damon Runyon Cancer Research Foundation DRG-2143-13 (N.A.), Ludwig Center at Memorial Sloan Kettering Cancer Center and the US National Institutes of Health (NIH) grant T32 A1007621 (N.A.) and R37 AI034206 (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.

Author information

Affiliations

  1. Howard Hughes Medical Institute and Ludwig Center at Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA

    • Nicholas Arpaia
    • , Clarissa Campbell
    • , Xiying Fan
    • , Stanislav Dikiy
    • , Joris van der Veeken
    • , Paul deRoos
    • , Paul J. Coffer
    •  & Alexander Y. Rudensky
  2. Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA

    • Nicholas Arpaia
    • , Clarissa Campbell
    • , Xiying Fan
    • , Stanislav Dikiy
    • , Joris van der Veeken
    • , Paul deRoos
    • , Paul J. Coffer
    •  & Alexander Y. Rudensky
  3. Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA

    • Hui Liu
    •  & Justin R. Cross
  4. Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Duesseldorf, Duesseldorf 40225, Germany

    • Klaus Pfeffer
  5. Department of Cell Biology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands

    • Paul J. Coffer

Authors

  1. Search for Nicholas Arpaia in:

  2. Search for Clarissa Campbell in:

  3. Search for Xiying Fan in:

  4. Search for Stanislav Dikiy in:

  5. Search for Joris van der Veeken in:

  6. Search for Paul deRoos in:

  7. Search for Hui Liu in:

  8. Search for Justin R. Cross in:

  9. Search for Klaus Pfeffer in:

  10. Search for Paul J. Coffer in:

  11. Search for Alexander Y. Rudensky in:

Contributions

N.A., C.C. and X.F. performed experiments and analysed data, with general assistance from S.D. and assistance from P.d. for HPLC, P.J.C. for immunoprecipitation of acetylated Foxp3 and J.v.d.V. for ChIP–qPCR experiments. H.L. and J.R.C. performed LC–MS. N.A., C.C., X.F. and A.Y.R. designed and interpreted experiments. K.P. provided Gpr109a mice. N.A. and A.Y.R. wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Alexander Y. Rudensky.

Supplementary information

PDF files

  1. 1.

    Supplementary Figures

    This file contains Supplementary Figures 1-6.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature12726

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.